INVITRO SUSCEPTIBILITIES OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI TO AZITHROMYCIN AND ERYTHROMYCIN

被引：14

作者：

TAYLOR, DE ^{[1
]}

CHANG, N ^{[1
]}

机构：

[1] UNIV ALBERTA,DEPT MICROBIOL,EDMONTON T6G 2H7,ALBERTA,CANADA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1991年 / 35卷 / 09期

关键词：

D O I：

10.1128/AAC.35.9.1917

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

MICs of azithromycin and erythromycin for 20 Campylobacter coli and 20 Campylobacter jejuni strains were determined. The results demonstrated that, for Campylobacter species, all high-level erythromycin-resistant strains were also resistant to azithromycin and that azithromycin did not exhibit increased potency in comparison with that of erythromycin.

引用

页码：1917 / 1918

页数：2

共 14 条

[1] SYNTHESIS, INVITRO AND INVIVO ACTIVITY OF NOVEL 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN A DERIVATIVES - A NEW CLASS OF MACROLIDE ANTIBIOTICS, THE AZALIDES [J].

BRIGHT, GM ;

NAGEL, AA ;

BORDNER, J ;

DESAI, KA ;

DIBRINO, JN ;

NOWAKOWSKA, J ;

VINCENT, L ;

WATROUS, RM ;

SCIAVOLINO, FC ;

ENGLISH, AR ;

RETSEMA, JA ;

ANDERSON, MR ;

BRENNAN, LA ;

BOROVOY, RJ ;

CIMOCHOWSKI, CR ;

FAIELLA, JA ;

GIRARD, AE ;

GIRARD, D ;

HERBERT, C ;

MANOUSOS, M ;

MASON, R .

JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1029-1047

[2]

BRUNTON WAT, 1978, LANCET, V2, P1385

[3] MACROLIDE, LINCOSAMIDE AND STREPTOGRAMIN RESISTANCE IN CAMPYLOBACTER-JEJUNI COLI [J].

BURRIDGE, R ;

WARREN, C ;

PHILLIPS, I .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (03) :315-321

[4] INVITRO AND INVIVO UPTAKE OF AZITHROMYCIN (CP-62,993) BY PHAGOCYTIC-CELLS - POSSIBLE MECHANISM OF DELIVERY AND RELEASE AT SITES OF INFECTION [J].

GLADUE, RP ;

BRIGHT, GM ;

ISAACSON, RE ;

NEWBORG, MF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) :277-282

[5] COMPARATIVE INVITRO ACTIVITIES OF NEW 14-MEMBERED, 15-MEMBERED, AND 16-MEMBERED MACROLIDES [J].

HARDY, DJ ;

HENSEY, DM ;

BEYER, JM ;

VOJTKO, C ;

MCDONALD, EJ ;

FERNANDES, PB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1710-1719

[6] ANTI-MICROBIAL SUSCEPTIBILITY OF CAMPYLOBACTER-JEJUNI WITH SPECIAL REFERENCE TO RESISTANCE PATTERNS OF CANADIAN ISOLATES [J].

KARMALI, MA ;

DEGRANDIS, S ;

FLEMING, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (04) :593-597

[7]

KARMALI MA, 1982, CAMPYLOBACTER EPIDEM, P218

[8] INVITRO ACTIVITY OF AZITHROMYCIN AGAINST VARIOUS GRAM-NEGATIVE BACILLI AND ANAEROBIC-BACTERIA [J].

KITZIS, MD ;

GOLDSTEIN, FW ;

MIEGI, M ;

ACAR, JF .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :15-18

[9] SPECTRUM AND MODE OF ACTION OF AZITHROMYCIN (CP-62,993), A NEW 15-MEMBERED-RING MACROLIDE WITH IMPROVED POTENCY AGAINST GRAM-NEGATIVE ORGANISMS [J].

RETSEMA, J ;

GIRARD, A ;

SCHELKLY, W ;

MANOUSOS, M ;

ANDERSON, M ;

BRIGHT, G ;

BOROVOY, R ;

BRENNAN, L ;

MASON, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1939-1947

[10]

TENOVER F, COMMUNICATION

← 1 2 →